Background
Claudin-1 is a member of the claudin family of tight junction proteins whose traditional roles involve maintenance of the epithelial barrier function. However, in recent years many claudins have been shown to be important players in several types of cancers, in capacities beyond barrier regulation, when their expression levels/patterns are altered. In most of these studies however, loss of the TJ proteins have contributed to the deregulation of the mechanical aspects of tumor progression such as migration[
1], and invasion[
2,
3]. By contrast, we and others have shown that the claudin-1 expression is upregulated in human colon cancer[
4] and that modulation of claudin-1 expression positively regulates the tumor growth and metastasis in xenograft models using colon cancer cells. However, it remains unclear if modulation of claudin-1 expression even in normal colonic epithelial cells would serve a tumor promoting role, under conditions permissive of colon cancer growth, and the underlying molecular mechanisms.
Importantly, in recent studies, we have demonstrated a role for claudin-1 in the maintenance of normal intestinal homeostasis whereby intestinal epithelial cell (IEC)-specific constitutive expression of claudin-1 (Villin-claudin-1 Tg mice; Cld-1Tg) altered goblet cell differentiation by promoting Notch activation[
5]. Importantly, Cl-1Tg mice also demonstrated enhanced severity of Dextran sodium sulfate (DSS)-induced colitis and impaired recovery from colitis-induced epithelial injury, which was attributed to the decreased mucosal protection due to the loss of the primary component of the goblet cells and anti-microbial defense, Mucin-2. These findings supported a previously reported connection between inflammation and claudin-1 expression using specimens from patients with active IBD and colitis-associated cancer[
6,
7].
To determine whether IEC-specific claudin-1 overexpression would also promote colon tumorigenesis, we generated APC-Cldn1 mice by crossing Cld-1Tg mice with APC
Min mice, the commonly used mouse model of intestinal tumorigenesis. The APC
Min mouse model replicates the common mutation inherited in Familial Adenamatous polyposis disease (FAP), which predisposes patients to spontaneous colorectal cancer. Notably, the APC
Min mice regularly develop adenomas of the small intestine however they rarely develop those of large bowel origin[
8]. Consequently, these mice are widely used to study the role of the specific genes of interest in the regulation of colorectal cancer in conjunction with the APC mutation.
Here, we show that claudin-1 overexpression in APC
Min mice significantly increases colon tumor growth as well as frequency while decreasing the mice survival. In concurrence with our previous reports, tumors in APC-Cldn1 mice demonstrate elevated levels of Wnt- and Notch-signaling. Furthermore, an upregulated pro-inflammatory gene signature including the IL-23/IL-17-signaling and suppressed anti-microbial defense mechanisms marked these tumors. Notably, these dysregulations associated with an increase in mucosal permeability and bacterial translocation in APC-Cldn1 mice, which is reported to upregulate IL-23/IL-17 signaling[
9], and may aid in the promotion of colon cancer. Taken together, our current studies provide a clear insight into the role of claudin-1 protein in the regulation of colorectal cancer potentially by upregulating the Notch- and Wnt-signaling and mucosal inflammation.
Discussion
Claudin-1 overexpression has been frequently observed in colon cancer, and mucosal inflammation, however the significance of its upregulation is not clearly understood. We utilized the APC
Min
model of colon cancer to identify the role of claudin-1 in tumorigenesis and were able to determine that claudin-1 overexpression contributes to colon tumor growth and progression. The APC mice have a limited life span, which is often attributed to the tumor burden of the small intestine and cachexia that develops as a result. Considering the advanced nature of the intestinal tumors and increased colonic tumor burden in APC-Cldn1 mice, we believe that the advanced and increased tumors contributed to the decreased survival of APC-Cldn1 mice. However considering the key role of inflammation in tumor progression in our mice, its contribution to decreased survival can’t be ruled out.
The Wnt- and Notch-pathways have important roles in normal colonic development and are known to be dysregulated in intestinal diseases, most notably colorectal cancer. Claudin-1 is a known target of Tcf/Lef signaling however also seems to participate in the potentiation of this pathway as we have seen further upregulation of Wnt signaling in the APC-Cldn1 tumors. This also supports our previously published data of claudin-1 regulating E-cadherin expression through modulation of Wnt/β-catenin activity[
20]. It is of interest to note that Wnt-target genes that are upregulated with claudin-1 overexpression are involved in stem cell maintenance (Figure
3C), as opposed to those that are well known oncogenes, cyclin D1 and c-myc, of which we observed no change in mRNA expression (data not shown). CD44 has been shown to be a marker of cancer stem cells and responsible for conferring tumorigenic properties to cells[
21,
22]. Lgr5 is an established intestinal stem cell marker and has also been shown to regulate tumorigenic capacity of colon cancer cells[
23,
24]. Although not identified as a stem cell marker, Axin2 is an established target of Wnt signaling and contributes to colon cancer cell invasion[
25]. Further studies would establish whether claudin-1 could directly regulate expression of these genes.
In previous studies we showed that claudin-1 increases Notch-activity. We were able to detect increased Notch activity as measured by Hes1 and Math1 mRNA expression (Figure
3D). As crosstalk between the Notch- and Wnt-pathways is not a new concept, it is possible that claudin-1 could rest at the hub of this interaction. The microarray presented several shared genes (Table
2) between these pathways that were upregulated in tumors from APC-Cldn1 mice. Additionally, Lgr5 expression, which was increased by claudin-1 overexpression, can regulate Notch-activity[
24].
We have shown in Cld-1-Tg mice and colon cancer cell lines that increased claudin-1 expression can increase Notch signaling with downregulation of expression of mucosal defense genes Muc2, KLF4 and Tff3[
5] and in this study microarray data and qRT-PCR analysis confirmed downregulation of these genes in the tumors of APC-Cldn1 mice. These genes, known to be important in the protection against inflammation and luminal antigens, have also been shown to be important in the protection against tumorigenesis. Klf4 expression can regulate tumor growth in mouse xenograft studies and tumor number in APC mediated tumorigenesis[
14,
26]. Similarly, Tff3 expression can also regulate tumor growth[
27]. Muc2 deficient mice, known to develop spontaneous colitis, have been shown to robustly increase colon tumorigenesis when combined with APC mutation[
13]. Interestingly, partial loss of Muc2 contributed to the tumor development in APC
Min mice in a fashion similar to APC-Cld-1 mice. These studies support a postulation that claudin-1 expression upregulate Notch signaling to regulate defense gene expression and their loss contributes to claudin-1 mediated tumorigenesis. Additionally these findings provide further support of a potential role for inflammation in claudin-1-mediated colon cancer progression. Of interest, we have recently demonstrated that constitutive claudin-1 expression induces Notch signaling which in turn suppresses goblet cell differentiation and muc-2 expression to compromise the mucus barrier and thus increase susceptibility to colitis in Cld-1Tg mice[
5]. We predict that the compromised mucus barrier along with increased permeability due to the early onset of the adenomas help facilitate increased translocation of the luminal bacteria and microbial products into the mucosa of APC-Cld-1 mice, which in turn promotes inflammation, a driver of colon tumor progression. We indeed confirmed increased expression of cytokines commonly upregulated during inflammation in APC-Claudin-1 tumors (Figure
4B).
Sporadic cancer and colitis-associated cancers are frequently studied as two distinct processes separated by their initiating stimulus, loss of the APC or inflammatory bowel disease, respectively. Studies, including this work, have highlighted a cooperation of the two, beyond genetic manipulation of specific inflammatory mediators[
9,
13,
28,
29]. This suggests that whereas inflammation is generally thought to be a result of host response to tumor development in "hereditary" development of colon cancer, it may actually function to fuel tumor progression. We employed a model that accelerates the formation of colonic tumors in APC
Min mice to further examine the role of claudin-1 in tumorigenesis. With this model we were able to track tumor development in both APC
Min and APC-Cldn1 mice in a shorter amount of time. Colon tumors were significantly increased and we also observed that in this model APC-Cldn1 mice developed tumors earlier than APC
Min mice, further confirming our results from the sporadic model.
Loss of the mucosal defense genes and the resulting increased inflammation are factors that can be regulated by a breech in barrier dynamics. The role of claudin-1 in the regulation of barrier function was established shortly after its discovery. Here we show that claudin-1 overexpression in APC
Min mice induces mucosal permeability by inducing early adenoma formation. This change in permeability along with mucus barrier defect in these mice allows commensal bacteria to freely flow in to the intestinal mucosa. Indeed, it has been shown that bacteria can contribute to colon tumorigenesis[
30]. Specifically, APC mice housed in a germ-free environment produced less tumors than those placed in normal housing conditions[
31]. In accordance, APC-Cldn1 mice exhibited increased bacterial translocation and colon tumors, further supporting a role for the aid of commensal bacteria in the regulation of sporadic colon tumorigenesis.
Recently, studies involving a separate model of APC-Cre-mediated colon tumorigenesis showed that tumor formation was mediated by IL-23 signaling in response to barrier defect and increased bacterial products[
9]. Indeed we observed increased IL-23 and its downstream targets, IL-17 and IL-6. Since IL-23 signaling is activated in response to bacteria, it is possible in this model that inflammation arises downstream of claudin-1 activation in response to increased bacterial translocation. It is also of interest to note that supernatants of colonic ex vivo explants from
Muc2/APC mice had increased IL-23 secretion[
13]. Additionally, many of the genes (Lcn2, Ccl28, and CCl6) found to be upregulated in the microarray of APC-Cldn1 mice were also found to be upregulated in the microarray of
Muc2/APC mice[
13].
Studies into the role of tight junction proteins in cancer have focused on their role in mechanical aspects of tumorigenesis, i.e., migration and invasion, which is not surprising considering the classical function of these proteins. It is ideal to think of alterations in tight junctions affecting latter stages of tumorigenesis as it relates to loss of polarity and contribution to EMT-like changes, thus facilitating metastasis. Our work shows a causative role of claudin-1 in earlier stages tumorigenesis. We have shown that increased expression of a tight junction protein can cause early adenoma formation which in turn causes enhanced permeability, increased bacterial translocation and thus inflammation with induction of IL-23 signaling to increase colonic tumorigenesis. This observation suggests claudin-1 has an active role in progressing tumorigenesis as opposed to being altered as a result. It is still unclear as to the sequence of events during tumorigenesis in relation to the order of inflammation and claudin-1 upregulation. It is possible to hypothesize a feedback loop may exist that maintains elevated inflammation. Claudin-1 expression has been shown to be regulated by cytokines[
6,
32], and here we have shown that claudin-1 can mediate inflammation through a mechanism involving reduced Muc2 and increased bacterial translocation. Further studies will investigate the specific mechanism by which claudin-1 upregulates IL-23 signaling beyond bacterial upregulation.
Methods
Mice
To obtain APC
Min/+-Villin-Cldn1Tg mice (APC-Cldn1), APC
Min males purchased from Jackson Laboratories (Bar Harbor, Maine) were bred with Villin-Claudin-1-Tg females. Claudin-1 overexpression was assessed by PCR as described previously[
5] on genomic DNA isolated from tail snips using DNA isolation buffer (Viagen Biotech; Los Angeles, CA). Identification of the mutated APC allele was performed using a modified protocol from Jackson Laboratories. APC and APC-Cldn1 littermates were monitored for signs of morbidity including hunched posture, anemia, and body weight loss and sacrificed according to the guidelines of Vanderbilt University Institutional Animal Care and Use Committee (IACUC). Accelerated tumorigenesis was induced by administering 10-week-old mice dextran sulphate sodium (DSS 2%) in their drinking water. Mice were monitored throughout duration of the experiment as described previously[
5], and examined intermittently via colon endoscopy.
Tissue processing
As described previously, the colon and the small intestine were dissected and flushed with PBS, opened flat and formalin fixed using the Swiss roll method. Further processing was performed by the Vanderbilt Translational Pathology Shared Resource Core. Distal and proximal sections of the colon were snap-frozen and stored at -80°C for further analysis. Where applicable, colonic tumors were quantified. Tumors were either isolated and frozen for further analysis, or left in the colon to be processed for embedding and H&E staining.
Tumor size measurements
Tumor area was calculated using Axiovision 4 digital imaging processing software (Release 4.8.1, Carl Zeiss Imaging) by outlining tumors of three to four mice each of APC and APC-Cldn1 mice.
Immunohistochemistry
Immunostaining of the paraffin-embedded tissues was performed as described previously[
5] using VectaStain ABC kit (Vector Laboratories) and the indicated antibodies. Images were obtained using a Zeiss light microscope.
RNA isolation and microarray analysis
Total RNA was isolated from tumors excised from the colon of APC and APC-Claudin-1 mice using Qiagen RNAeasy Mini kit with DNAse digestion step performed. The integrity of the RNA was determined by performing formaldehyde gel electrophoresis. Samples displaying two bands, corresponding to the 18S and 28S subunits, and having an A260/A280 of ~1.8 were used for experiments. Total RNA was isolated from snap-frozen tumors, as described above, and RNA integrity was measured. Samples were submitted to the Vanderbilt Microarray Shared Resource.
Quantitative reverse transcription-PCR
Total RNA (1ug) of each sample was reverse transcribed using the iScript cDNA Synthesis Kit (Bio-Rad). Each qRT-PCR reaction contained SYBR Green Master Mix, the indicated primer sets and 25 ng of cDNA. Samples were loaded in triplicates on 96 well plates and run on a Bio-Rad iCycler. Ct values were utilized to calculate fold change and normalization was performed using beta-actin.
Permeability assay
Assessment of intestinal permeability to 4 kDa FITC-dextran was performed as described previously by rectal administration[
5].
Bacterial translocation
Translocation of bacteria was assessed by detecting the amount of bacterial 16S rDNA using qRT-PCR and specific primers for conserved regions of the bacterial 16S rDNA[
33]. Genomic DNA was isolated from the distal colon of three mice per group and 25 ng was used per reaction. The mouse
Selp gene was utilized as normalization gene.
Statistics
Statistical analyses were performed using Graphpad Prism software (San Diego, CA) for t-test analysis where comparisons between two groups were involved. SPSS software (College Station, TX) was utilized for analyses of Logistic regression (for binary outcomes) and Chi2 (for categorical). P values less than 0.05 were considered significant.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Competing interests
The authors declare that they have no competing interest.
Authors’ contributions
JLP: Conception and design, acquisition of data, analysis and interpretation of data, writing of the manuscript, RA: Acquisition of data, analysis and interpretation of data. AAB: Acquisition of data, analysis and interpretation of data. MKW: analysis and interpretation of data, ABS: Obtained funding, conception and design, manuscript writing and PD: Obtained funding, conception and design, study supervision, writing of the manuscript. All authors read and approved the final manuscript.